Japan PMDA
Material regulatory developments from Pharmaceuticals & Medical Devices Agency are tracked daily by Cresthaven Analytics. Over the last 90 days, 1 material brief relevant to professionals operating in the healthcare & life sciences sector have been published below. Each brief is sourced directly from the primary regulatory feed, summarized for institutional readers, and scored for materiality.
Recent material activity
-
PMDA and MHLW issue revised drug package insert precautions following new risk identification
Japan's Pharmaceuticals and Medical Devices Agency (PMDA) and Ministry of Health, Labour and Welfare (MHLW) issued a revision to PRECAUTIONS sections in drug package inserts, published May 3, 2026. The revision follows P…
Read a full sample brief →
Get every Japan PMDA brief delivered the day it lands
From $149/month
Cresthaven Analytics monitors Pharmaceuticals & Medical Devices Agency continuously, applying institutional materiality scoring to every release. Subscribers receive structured briefs via email, portal, and (Executive tier and above) real-time alerts.
View all tiers →